Lower back pain: Therapy in the context of evidence-based medicine and new possibilities
Abstract
About 15% (12–30%) of the population experience pain in the lower back – LBP (lumbosacral region). Back pain is nonspecific in most cases (90–95%). In the past decade, the number of patients with back pain has remained virtually unchanged while the cost of medical care for this category of patients has risen manifold, which constitutes one of the most important problems in health care today. The paper considers main approaches to drug and nondrug therapies for nonspecific acute LBP in the context of current evidence-based medicine data, as well as new possibilities of effective and safe relief of pain syndrome in this group of patients.
About the Author
Aleksei Vladimirovich Sergeev
Clinical Neurology Research and Education Center, I.M. Sechenov First Moscow State Medical University
Russian Federation
Russian Federation
References
1. <div><p>Airaksinen O, Brox JI, Cedraschi C et al. Chapter 4. European guidelines for the management of chronic nonspecifi c low backpain. Eur Spine J. 2006;15 suppl 2:S192–300.</p><p>Walker BF. The prevalence of low back pain: a systematic review of the literature from 1966 to 1998. Journal of Spinal Disorders. 2000;13(3):205–17. DOI: 10.1097%2F00002517-200006000-00003.</p><p>Подчуфарова ЕВ. Яхно НН. Боль в спине. Москва: ГЕОТАР Медиа; 2010. 368 c. [Podchufarova EV. Yakhno NN. Bol' v spine. Moscow: GEOTAR Media; 2010. 368 p.]</p><p>Waddell G. The clinical course of low back pain. In: The back pain revolution. Edinburgh: Churchill Livingstone. 1998. Р. 103–17.</p><p>Government Accountability Office. Medicare Part B imagingservices: rapid spending growth and shift to physician officesindicate need for CMA to consider additional managementpractices. Washington, DC: Government Accountability Office; 2008.</p><p>Andersson GB. Low back pain. J Rehabil Res Dev. 1997;34:9–10.</p><p>Loney PL, Stratford PW. The prevalence of low back pain in adults: a methodological review of theliterature. Phys Ther. 1999;79(4):384–96.</p><p>Павленко СС. Эпидемиология боли. Неврологический журнал. 1999;4(1):41–6. [Pavlenko SS. Epidemiologiya boli. Nevrologicheskiy zhurnal. 1999;4(1):41–6.]</p><p>Боль: руководство для врачей и студентов. Под ред. акад. Яхно НН. Москва: МЕДпресс-информ; 2009. 304 с. [Bol': rukovodstvo dlya vrachey i studentov. Pod red. akad. Yakhno NN. Moscow: MEDpress-inform; 2009. 304 p.]</p><p>Матросов ДН, Галушко ЕА, Эрдес ШФ. Эпидемиология болей в нижней части спины в амбулаторной практике. Боль. 2009;4(25):23–8. [Matrosov DN, Galushko EA, Erdes ShF. Epidemiologiya boley v nizhney chasti spiny v ambulatornoy praktike. Bol'. 2009;4(25):23–8.]</p><p>Deyo RA, Rainville J, Kent DL. What can the history and physical examination tell us about low backpain? JAMA. 1992;268(6):760–5.</p><p>Anderson R. A case study in integrative medicine: alternative theories and the language of biomedicine. J Altern Complement Med. 1999;5(2):165–73; discussion 175-6. DOI: 10.1089%2Facm.1999.5.165.</p><p>Natvig B, Bruusgaard D, Eriksen W. Localized low back pain and low back pain as part of widespreadmusculoskeletal pain: two different disorders? A cross-sectionalpopulation study. J Rehabil Med. 2001;33(1):21–5.</p><p>Van Tulder MW. Low back pain. Best Practice and Research. Clinical Rheumatology. 2002;16:761–75.</p><p>Endean A, Palmer KT, Coggon D. Potential of magnetic resonanceimaging findings to refine case definition for mechanical low backpain in epidemiological tudies: a systematic review. Spine (Phila Pa 1976). 2011;36(2):160–69. DOI: 10.1097/BRS.0b013e3181cd9adb.</p><p>Balague F, Mannion AF, Pellise F, Cedraschi C. Non-specific low back pain. Lancet. 2012 Feb 4;379(9814):482–91. DOI: 10.1016/S0140-6736(11)60610-7. Epub 2011 Oct 6.</p><p>Heneweer H, Vanhees L, Picavet HS. Physical activity and low backpain: a U-shaped relation? Pain. 2009;143(1–2):21–5. DOI: 10.1016/j.pain.2008.12.033. Epub 2009 Feb 12.</p><p>Shiri R, Karppinen J, Leino-Arjas P et al. The association between obesity and low back pain: a meta-analysis. Am J Epidemiol. 2010;171(2):135–54. DOI: 10.1093/aje/kwp356. Epub 2009 Dec 11.</p><p>Verbunt JA, Smeets RJ, Wittink HM. Cause or effect? Deconditioning and chronic low back pain. Pain. 2010;149(3):428–30. DOI: 10.1016/j.pain.2010.01.020. Epub 2010 Feb 12.</p><p>Kalichman L, Hunter DJ. The genetics of intervertebral discdegeneration. Familial predisposition and heritability estimation. Joint Bone Spine. 2008;75(4):383–87. DOI: 10.1016/j.jbspin.2007.11.003. Epub 2008 Apr 29.</p><p>Karppinen J, Solovieva S, Luoma K et al. Modic changes and interleukin 1 gene locuspolymorphisms in occupational cohort of middle-aged men. Eur Spine J. 2009;18(12):1963–70. DOI: 10.1007/s00586-009-1139-x. Epub 2009 Aug 22.</p><p>Kent P, Keating J. Do primary-care clinicians think that nonspecificlow back pain is one condition? Spine (Phila Pa 1976). 2004;29(9):1022–31.</p><p>Kamper SJ, Maher CG, Hancock MJ et al. Treatment-basedsubgroups of low back pain: a guide to appraisalof research studies and a summary of current evidence. Best Pract Res Clin Rheumatol. 2010; 24(2):181–91. DOI: 10.1016/j.berh.2009.11.003.</p><p>Dionne CE, Dunn KM, Croft PR, et al. A consensus approachtoward the standardization of back pain definitions for use inprevalence studies. Spine (Phila Pa 1976). 2008;33(1):95–103. DOI: 10.1097/BRS.0b013e31815e7f94.</p><p>Chou R, Shekelle P. Will this patient develop persistent disablinglow back pain? JAMA. 2010;303(13):1295–302. DOI: 10.1001/jama.2010.344.</p><p>Burton AK, Balague F, Cardon G et al. Chapter 2. Europeanguidelines for prevention in low back pain: November 2004. Eur Spine J. 2006;15 suppl 2:S136–68.</p><p>Dahm KT, Brurberg KG, Jamtvedt G, Hagen KB. Advice to rest in bed versus advice to stay active for acute low-back pain and sciatica. Cochrane Database Syst Rev. 2010;(6):CD007612. DOI: 10.1002/14651858.CD007612.pub2.</p><p>Vroomen PC, de Krom MC, Wilmink JT et al. Lack of effectiveness of bed rest for sciatica. N Engl J Med. 1999;340(6):418. DOI: 10.1056%2FNEJM199902113400602.</p><p>Krismer M, van Tulder M; Low Back Pain Group of the Bone and Joint Health Strategies for Europe Project. Strategies for prevention and management of musculoskeletal conditions. Low back pain (non-specific). Best Pract Res Clin Rheumatol. 2007 Feb;21(1):77–91.</p><p>Linton SJ, van Tulder MW. Preventive interventions for back and neck pain problems: what is the evidence? Spine (Phila Pa 1976). 2001;26(7):778–87. DOI: 10.1097%2F00007632-200104010-00019.</p><p>Choi BK, Verbeek JH, Tam WW, Jiang JY. Exercises for prevention of recurrences of low-back pain. Cochrane Database Syst Rev 2010;(1): CD006555. DOI: 10.1002/14651858.CD006555.pub2. Review.</p><p>Roelofs PD, Deyo RA, Koes BW et al. Non-steroidal anti-inflammatory drugs for low back pain. Cochrane Database Syst Rev. 2008;(1): CD000396. DOI: 10.1002/14651858.CD000396.pub3. Review.</p><p>Chou R, Qaseem A, Snow V et al. Diagnosis and treatment of low back pain: a joint clinical practice guideline from the American College of Physicians and the American Pain Society. Ann Intern Med. 2007;147(7):478–91. DOI: 10.7326%2F0003-4819-147-7-200710020-00006.</p><p>Алексеев ВВ. Ступенчатая терапия НПВП острого болевого синдрома в пояснично-крестцовой области. Эффективная фармакотерапия в неврологии и психиатрии. 2010;4:22–8. [Alekseev VV. Stupenchataya terapiya NPVP ostrogo bolevogo sindroma v poyasnichno-kresttsovoy oblasti. Effektivnaya farmakoterapiya v nevrologii i psikhiatrii. 2010;4:22–8.]</p><p>Алексеев ВВ. Диагностика и лечение острых поясничных болей. Consilium Medicum. 2009;11(2):42–6. [Alekseev VV. Diagnostika i lechenie ostrykh poyasnichnykh boley. Consilium Medicum. 2009;11(2):42–6.]</p><p>Эрдес ШФ. Неспецифическая боль в нижней части спины. Клинические рекомендации для участковых терапевтов и врачей общей практики. Москва: КомплектСервис; 2008. 70 c. [Erdes ShF. Nespetsificheskaya bol' v nizhney chasti spiny. Klinicheskie rekomendatsii dlya uchastkovykh terapevtov i vrachey obshchey praktiki. Moskva: KomplektServis; 2008. 70 p.]</p><p>Каратеев АЕ, Яхно НН, Лазебник ЛБ и др. Применение нестероидных противовоспалительных препаратов. (Клинические рекомендации). Москва: ИМА–ПРЕСС; 2009. 168 с. [Karateev AE, Yakhno NN, Lazebnik LB i dr. Primenenie nesteroidnykh protivovospalitel'nykh preparatov. (Klinicheskie rekomendatsii). Moscow: IMA–PRESS; 2009. 168 p.]</p><p>Forrest JB. Ketorolac, diclofenac, and ketoprofen are equally safe for pain relief after major surgery. Br J Anaesth. 2002;88(2):227–33.</p><p>Veenema KR, Leahey N, Schneider S. Ketorolac versus meperidine: ED treatment of severe musculoskeletal low back pain. Am J Emerg Med. 2000;18(4):404–7. DOI: 10.1053%2Fajem.2000.7314.</p><p>Jelinek GA. Ketorolac versus morphine for severe pain. Ketorolac is more effective, cheaper, and has fewer side effects. BMJ. 2000;321(7271):1236–7.</p><p>Верткин АЛ, Тополянский АВ, Вовк ЕЙ. Место кеторолака в терапии острых болевых синдромов на догоспитальном этапе. Consilium Medicum. 2006;8(2):86–90.</p><p>[Vertkin AL, Topolyanskiy AV, Vovk EY. Mesto ketorolaka v terapii ostrykh bolevykh sindromov na dogospital'nom etape. Consilium Medicum. 2006;8(2):86–90.]</p><p>Mukherjee D, Nissen SE, Topol EJ. Risk of cardiovascular events associated with selective COX-2 inhibitors. JAMA. 2001;286(8):954–9. DOI: 10.1001%2Fjama.286.8.954.</p><p>McGettigan P, Henry D. Cardiovascular risk and inhibition of cyclooxygenase: a systematic review of the observational studies of selective and nonselective inhibitors of cyclooxygenase 2. JAMA. 2006;296(13):1633–44. DOI: 10.1001%2Fjama.296.13.jrv60011. Epub 2006 Sep 12.</p><p>Gabriel SE, Jaakkimainen L, Bombardier C. Risk for serious gastrointestinal complications related to the use of non-steroidal antiinflammatory drugs: meta-analysis. Ann Intern Med. 1991;115(10):787–96.</p><p>Borhade N, Pathan AR, Halder S et al. NO-NSAIDs. Part 3: nitric oxide-releasing prodrugs of non-steroidal anti-inflammatory drugs. Chem Pharm Bull (Tokyo). 2012;60(4):465–81. DOI: 10.1248%2Fcpb.60.465.</p><p>Marcolongo R, Frediani B, BiasiG et al. A meta-analysis of the tolerability of amtolmetin guacil, a novel, effective nonsteroidal anti-inflammatory drug, compared with established agents. Clin Drug Invest. 1999 Feb;17(2):89–96.</p><p>Riezzo G, Chiloiro M, Montanaro S. Protective effects of amtometinguacylverus placebo diclofenac and mioprostol in healthy volunteers evaluated as gastric electrical activity in alcohol-induced stomach damage. Dig Dis Sci. 2001;46(8):1797–1804.</p><p>Li YH, Li J, Huang Y et al. Gastroprotective effect and mechanism of amtolmetinguacyl in mice. World J Gastroenterol. 2004;10(24):3616–20.</p><p>Van Tulder MW, Touray T, Furlan AD et al. Muscle relaxants for non-specific low back pain. Cochrane Database Syst Rev. 2003;(2):CD004252. DOI: 10.1002%2F14651858.CD004252.</p><p>Beebe FA, Barkin RL, Barkin S. A clinical and pharmacologic review of skeletal muscle relaxants for musculoskeletal conditions. Am J Ther. 2005;12(2):151–71.</p><p>Berry H, Hutchinson DR. Tizanidine and ibuprofen in acute low–back pain: Results of a double–blind multicentre study in general practice. J Int Med Res. 1988;16(2):83–91.</p><p>Парфенов ВА. Причины, диагностика и лечение боли в нижней части спины. Неврология, нейропсихиатрия, психосоматика. 2010;(1):19–22. [Parfenov VA. Low back pain: causes, diagnosis and treatment. Nevrologiya, neyropsikhiatriya, psikhosomatika. 2010;(1):19–22.]</p><p>Martell BA, O’Connor PG, Kerns RD et al. Systematic review: opioid treatment for chronic back pain: prevalence, efficacy, and association with addiction. Ann Intern Med. 2007;146(2):116–27. DOI: 10.7326%2F0003-4819-146-2-200701160-00006.</p><p>Friedman BW, Holden L, Esses D et al. Parenteral corticosteroids for Emergency Department patients with non-radicular low back pain. J Emerg Med. 2006;31(4):365–70.</p><p>Walker BF, French SD, Grant W, Green S. Combined chiropractic interventions for low-back pain. Cochrane Database Syst Rev. 2010;(4):CD005427. DOI: 10.1002/14651858.CD005427.pub2.</p><p>Kalauokalani D, Cherkin DC, Sherman KJ et al. Lessons from a trial of acupuncture and massage for low back pain: patient expectations and treatment effects. Spine (Phila Pa 1976). 2001;26(13):1418–24. DOI: 10.1097%2F00007632-200107010-00005.</p><p>Foster L, Clapp L, Erickson M, Jabbari B. Botulinum toxin A and chronic low back pain: a randomized, double-blind study. Neurology. 2001;56(10):1290–3. DOI: 10.1212%2FWNL.56.10.1290.</p></div><br />
Review
For citations:
Sergeev A.V. Lower back pain: Therapy in the context of evidence-based medicine and new possibilities. Neurology, Neuropsychiatry, Psychosomatics. 2013;5(3):78-85. (In Russ.) https://doi.org/10.14412/2074-2711-2013-2346
Views: 1156
Email this article 